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Background: The selective removal or inhibition of pathogenic microbes with locally delivered antimicrobials 
when combined with scaling and root planing is often an effective approach for the managment of chronic perio-
dontitis.
Aim: To compare the clinical efficacy of tetracycline fibers and a xanthan based chlorhexidine gel in the treatment 
of chronic periodontitis.
Methods and materials: Thirty systemically healthy patients in the age group of 30-50 years suffering from genera-
lized chronic moderate periodontitis were selected. For each subject, two experimental sites were chosen that had 
probing depth >5mm and were located in symmetric quadrants and the sites were randomized at split mouth level 
with one receiving tetracycline fibers and the other chlorhexidine gel. Plaque score, bleeding score, probing pocket 
depth and relative attachment level gain was recorded on day 0 and at the end of 3 months. 
Results and conclusion: In both groups, there was statistically highly significant reduction in all the clinical para-
meters i.e. plaque score, bleeding score and probing pocket depth and relative attachment level gain was seen at di-
fferent time intervals. Local delivery of tetracycline and chlorhexidine is a safe, easy and efficacious method along 
with scaling and root planing in the treatment of chronic periodontitis. Inter-comparison of both local drug delivery 
agents with respect to clinical changes shows that tetracycline fibers are better than chlorhexidine gel for treatment 
of chronic periodontitis. Nevertheless, long term studies with more samples are suggested to further evaluate and 
compare the efficacy of both materials. 
Key Words: local delivery, periodontitis, tetracycline fibers, chlorhexidine gel.
Gill JS, Bharti V, Gupta H, Gill S. Non-surgical management of chronic 
periodontitis with two local drug delivery agents- A comparative study. J 
Clin Exp Dent. 2011;3(5):e424-9.
http://www.medicinaoral.com/odo/volumenes/v3i5/jcedv3i5p424.pdf
Article Number: 50490                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
e425
J Clin Exp Dent. 2011;3(5):e424-9.                                  Non surgical management of chronic periodontitis.
Introduction 
Periodontal diseases represent a group of localized mi-
crobial induced infections involving gingiva and suppor-
ting tissues of the teeth. The role of microorganisms in 
the etiology and progression of periodontitis is now well 
documented (1). Periodontal diseases are routinely trea-
ted by mechanical procedures which include meticulous 
scaling and root planing in conjunction with patient’s 
proper plaque control. Although mechanical therapy 
may provide long term stability for many patients, but 
it fails to eliminate the pathogenic bacteria completely 
and may not always result in complete elimination of 
the disease (2). 
Local delivery of antimicrobial agents into periodontal 
pocket has been extensively developed and investiga-
ted since late 1970’s (3). Local delivery of antimicro-
bial agents includes oral rinses, subgingival irrigation 
and controlled release delivery systems (4). Controlled 
release systems have received great interest and appear 
to hold some promise in periodontal therapy. They have 
been evaluated in several forms such as gels, strips, fi-
bers, chips, ointments etc and using different antimicro-
bial agents such as tetracycline, doxycycline, metronida-
zole, minocycline and chlorhexidine (5-10). Pioneering 
work by Goodson introduced the use of tetracycline as 
a local drug delivery agent for the treatment of perio-
dontal diseases (11). He and his coworkers developed a 
local drug delivery system consisting of a polymer and 
ethylene vinyl acetate impregnated with 25% tetracycli-
ne hydrochloride. One such local drug delivery system 
is available in the form of resorbable tetracycline fibers 
(Periodontal Plus AB®)   
Chlorhexidine is also a highly effective antimicrobial 
agent that has been extensively studied and shown to be 
effective as a mouthrinse against supragingival plaque 
bacteria in prevention of gingivitis and as a treatment 
for gingivitis (12) .Chlorhexidine has been used for lo-
cal drug delivery in various formulations such as mouth 
rinses, gels, sprays, varnishes, chips and subgingival 
irrigation devices (13-15).Chlorhexidine in form of gel 
has been used in varying concentrations such as 0.2%, 
1% and 2% (13-15). In the present study, xanthan based 
1.5% chlorhexidine gel was used as an adjunct to scaling 
and root planing .The aim of the present study was to 
compare the efficacy of tetracycline fibers (Periodontal 
Plus AB®) and chlorhexidine gel (Chlosite®) when used 
as an adjunct to scaling and root planing in the manage-
ment of chronic periodontitis. 
Material and Methods
Thirty systemically healthy patients in the age group of 30-
50 years (both male and female) suffering from generali-
zed chronic moderate periodontitis were selected amongst 
the patients visiting the Department of Periodontics, Govt. 
Dental College and Hospital, Patiala (Punjab). Patients 
did not receive any surgical or non surgical periodontal 
therapy in past 6 months and were not on any antibiotic 
therapy since past 3 months. Written informed consent 
was taken from each patient who participated in the stu-
dy and ethical clearance was obtained from the institutio-
nal committee. For each subject, two experimental sites 
were chosen that had probing depth >5mm and were lo-
cated in symmetric quadrants and after scaling and root 
planing, the two sites were randomized at split mouth 
level by flip of a coin and divided into two groups:
Group I:  Tetracycline fibers (Periodontal Plus AB®) 
were inserted into the periodontal pocket until pocket 
was filled. Coe pak® was then applied for 10 days. (Fi-
gure 1) 
Group II: After washing the selected site with distilled 
water and drying it, chlorhexidine gel (Chlosite®) was 
applied directly from the syringe into the pocket. Coe 
pak® was then applied for 10 days. (Figure 2) 
Recording of various clinical parameters was carried on 
Fig. 1. Showing Periodontal Plus AB®  fibers and insertion of fibres into the periodontal pocket
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day 0 (baseline) and subsequently recording of plaque 
score and bleeding score was made at the end of 1 month 
and 3 months, while probing pocket depth and relative 
attachment level was recorded on day 0 and at the end 
of 3 months. The course of the study was of 3 months 
duration. The significance of the differences in plaque 
index, bleeding score, probing pocket depth and relati-
ve attachment level for both the groups at different time 
intervals was assessed using paired t-test, while the in-
ter-comparison of both the groups was carried out using 
unpaired t-test.
Clinical Parameters 
Plaque Index (Quigley - Hein Plaque Index). 1. 
Probing pocket depth (using Williams’s calibrated 2. 
periodontal probe)
Bleeding Index (PBI modified by Muhlemann HR)3. 
Relative Attachment Level (Measurement using 4. 
customized acrylic stent)
Materials
Tetracycline Fibers (Periodontal Plus AB®) #: Resorba-
ble collagen fibers 25mg, impregnated with tetracycline 
hydrochloride containing approximately 1.7 ± 0.25mg 
tetracycline hydrochloride.
Chlorhexidine gel (Chlosite®)*: Xanthan based 1.5% 
chlorhexidine gel containing 0.5% fast releasing chlor-
hexidine digluconate and 1% in form of slow releasing 
chlorhexidine dihydrochloride. Xanthan is an optimum 
substrate for the formation of a stable gel that is easily 
extruded from a syringe needle. 
# Periodontal Plus AB®: Advanced  Bio Tech Products 
(Ltd), * Chlosite®: Ghimas,Italy   
                   
Results
Mean plaque score of both group I (Periodontal Plus 
AB®) and group II (Chlosite®) score at baseline (day 
0) and at the end of 1 month and 3 months was highly 
significant (p <0.001). On comparison of reduction in 
mean plaque score of group I (Periodontal Plus AB®) 
and group II (Chlosite®) at different time intervals it was 
found that reduction in plaque score after 1 month and 
3 months from baseline (day 0) was non-significant (p> 
0.05). (Table 1)
Mean papillary bleeding score of group I (Periodontal 
Plus AB®) and  group II (Chlosite®) at day 0 and at the 
end of 1 month and 3 months was highly significant (p< 
0.001).On comparison , reduction in mean papillary 
bleeding score between the two groups was significant 
(p< 0.05).(Table 2) 
Mean probing pocket depth of group I (Periodontal Plus 
AB®) and group II (Chlosite®) at day 0 and at the end of 
3 months was highly significant (p <0.001). On compa-
rison, reduction in mean probing pocket depth of group 
I (Periodontal Plus AB®) and group II (Chlosite®) after 
3 months from baseline was significant (p< 0.05).(Table 
Time interval Group Mean±SD ‘t’ value ‘p’ value Significance
After 1 month from baseline I 0.92±0.54 0.14 >0.05 NSII 0.95±0.58
After 3 months from baseline I 1.02±0.57 0.28 >0.05 NSII 0.97±0.52
# t-value calculated using unpaired t-test and p value used to determine the statistical significance
Table 1. Comparison of reduction in mean plaque score of group I (periodontal plus ab®) and group II (Chlosite®) at 1 month and 3 months 
from baseline (day 0)
Fig. 2. Showing Chlosite® gel and insertion of gel into the periodontal pocket
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3)
Mean relative attachment level of group I (Periodontal 
Plus AB®) and group II (Chlosite®) at day 0 and at the 
end of 3 months was highly significant (p< 0.001). On 
comparison of relative attachment level gain of group I 
(Periodontal Plus AB®) and group II (Chlosite®)  after 3 
months was significant (p< 0.05) (Table 4).
          
Discussion
Scaling and root planing in conjunction with proper 
plaque control results in alteration of the subgingi-
val environment that is sufficient, in most instances to 
improve periodontal health and arrest further loss of 
attachment(6).  Nevertheless, scaling and root planing 
alone may not predictably lead to complete elimination 
of the disease (6). Poor access to the bottom of deep poc-
kets and anatomical complexities may occasionally limit 
the efficacy of root planing (3). Moreover, some bacte-
ria have been shown to invade deep periodontal tissues, 
making mechanical therapy alone sometimes ineffective 
(16) and repopulation of scaled teeth from bacterial re-
servoirs in dentinal tubules may also be responsible for 
recurrence of the disease (3). 
Various antimicrobial agents have been administe-
red systemically as well as locally/topically by means 
of mouth rinses or irrigation solutions as an adjunct to 
scaling and root planing (14). However systemic admi-
nistration of antibiotics have been associated with side 
effects, while effectiveness of local delivery of antimi-
crobial agents in form of mouth rinses and subgingival 
irrigation has been limited due to inability of the drug to 
reach the site of action in adequate concentrations and 
the inability to localize and sustain at disease active sites 
(17) . Recently, advances in local delivery technology 
have resulted in control release of drugs that are suc-
cessful in maintaining effective drug concentration at a 
lower dosage in the periodontal pocket. 
It was observed in the present study, in both group I 
(tetracycline fibers) and group II (chlorhexidine gel), 
a reduction in mean plaque score that was statistically 
highly significant at both time intervals. Similar obser-
vations were made by Jeong et al (18), Friesen et al (19), 
Oosterwaal et al (20), Vinholis et al (12). This reduc-
tion in supragingival plaque score could be attributed to 
chemical control of subgingival plaque by tetracycline 
fibers which could also have an inhibitory effect on su-
pragingival plaque (21). Moreover, good oral hygiene 
practiced by patients during the entire study period could 
have also increased the reduction in plaque. However 
on comparison of mean plaque scores between group 
I and group II, statistically non-significant differences 
were recorded and the findings are in accordance with 
the study conducted by Unsal et al (15) who evaluated 
the effects of subgingivally placed 2% chlorhexidine gel 
and 10% tetracycline paste in periodontal pockets along 
with scaling and root planing. 
Bleeding on probing is an objective sign of inflamma-
tion. Research suggests that bleeding on probing often 
is the first sign of gingival inflammation. Reduction in 
mean bleeding score in both groups was highly signifi-
cant at both time intervals and the results are in accor-
dance with studies conducted by Minabe et al (22). In 
Time interval Group Mean±SD ‘t’ value ‘p’ value Significance
After 1 month  from baseline I 1.90±0.55 2.50 <0.05 SII 1.35±0.81
After 3 months from baseline
I 2.20±0.41
2.41 <0.05 SII 1.80±0.61
# t-value calculated using unpaired t-test and p value used to determine the statistical significance
Table 2. Comparison of reduction in mean papillary bleeding score of group I (Periodontal Plus AB®) and group II (Chlosite®) at 1 month and 3 
months from baseline (day 0)






# t-value calculated using unpaired t-test and p value used to determine the statistical significance
Table 3. Comparison of reduction in mean probing pocket depth (mm) of group I (Periodontal Plus AB®)  
and group II (Chlosite®) after 3 months from baseline (day 0).
Time interval Group Mean±SD ‘t’ value ‘p’ value Significance
After
3months from baseline
I 1.62±0.71 2.57 <0.05 SII 1.12±0.50
# t-value calculated using unpaired t-test and p value used to determine the statistical   significance
Table 4. Comparison of gain in mean Relative attachment level (mm) of group I (Periodontal Plus AB®)  
and group II (Chlosite®) after 3 months from baseline (day 0)
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the present study reduction in bleeding is due to resolu-
tion of gingival inflammation after scaling and root pla-
ning and well known antimicrobial effect of tetracycline 
(15, 23).Moreover, average gingival fluid concentration 
of 1500 µg/ml tetracycline has been observed during 
the first 10 days treatment period with Periodontal Plus 
AB®. Tetracycline is released in almost linear fashion for 
7-10 days. Similar findings were noted by Aimetti et al 
(6) and Heijl et al (25). On comparison of bleeding sco-
res between the two groups, reduction in mean papillary 
bleeding score was significant at both 1 and 3 months 
(p< 0.05). There was more reduction in the tetracycline 
group, which can be attributed to the fact that tetracycli-
ne offers better substantivity (23) and good binding and/
or penetration into the root surfaces (24) when compared 
to chlorhexidine and thereby maintaining antimicrobial 
effect for a longer time period.
Periodontal probing is one of the most widely used diag-
nostic tools for clinical assessment of connective tissue 
destruction and periodontal pocket depth in periodontal 
disease. In both groups the  reduction in mean probing 
pocket depth was highly significant and a similar  result 
was recorded by Goodson (11), Heijl et al (25), Rad-
var et al (3), Friesen et al (19) and Stabholz et al (23), 
Jeffcoat et al (14) and Vinholis et al (12). However, on 
comparison, mean probing pocket depth reduction bet-
ween group I and II was significant (p <0.05) at the end 
of 3 months, with better results in group I. Reduction in 
probing pocket depth in both the groups (Group I and II) 
is due to resolution of gingival inflammation after sca-
ling and root planing and to well known antimicrobial 
effects of both locally delivered drugs. Unsal et al (15) 
and Stabholz et al (23). 
Pocket depth might change from time to time even in un-
treated periodontal disease because of changes in gingi-
val margin, while changes in the level of attachment can 
be caused only by gain or loss of attachment and thus 
provide a better indication of the degree of periodontal 
destruction. There was highly significant gain (p <0.001) 
in both group I (tetracycline fibers) group II (chlorhexi-
dine gel) at the end of 3 months from baseline. Similar 
findings were recorded by Goodson (11), Heijl et al (25), 
Radvar et al (3), Friesen et al (19) and Stabholz et al 
(23), Jeffcoat et al (14),  Vinholis et al (12). 
On comparison, mean gain of attachment between 
group I and II was significant (p <0.05) at the end of 
3 months. There was more gain in relative attachment 
level in group I (tetracycline fibers), which may be due 
to substantivity of tetracycline for a longer period(23), 
collagenase inhibition property(26), anti-inflammatory 
effects and inhibition of bone resorption by tetracycline 
and their property to promote attachment of fibroblasts 
to root surface (27). Alveolar bone remineralization may 
also be triggered by elimination of infection by tetracy-
cline (6). There was highly significant reduction in pe-
riodontal pocket depth in group II (Chlosite®) at the end 
of 3 months from baseline (day 0), however reduction 
was lower when compared to group I (Periodontal Plus 
AB®) at the end of 3 months. This could be attributed to 
the fact that chlorhexidine offers a low subgingival subs-
tantivity and there is poor adsorption of the drug in the 
subgingival environment when compared to tetracycline 
(23). In a systematic review on the effects of subgingival 
chlorhexidine gel adminstration in treatment of chronic 
periodontitis, it was concluded that  the limited data cu-
rrently available on the effects of subgingival chlorhexi-
dine gel application do not justify its use in the treatment 
of chronic periodontitis (28) .However in a more recent 
randomized multicenter trial, xanthan based chlorhexi-
dine gel promoted greater pocket reductions and clinical 
attachment gains with better microbiologic and bioche-
mical outcomes compared with scaling and root planing 
alone (29). Moreover addition of chlorhexidine to xan-
than gum seem to improve the bioadhesive properties of 
this material and the cationic charges of chlorhexidine 
can interact with the anionic charges of the xanthan gum 
polymer, enhancing its gel structure and substantivity 
(30).This in concordance with our findings as xanthan 
based chlorhexidine gel was effective in reducing pocket 
probing depth and there was gain of attachment.
Conclusion
Both tetracycline fibers and chlorhexidine gel are an 
effective means of non-surgical treatment modality for 
the management of chronic periodontitis.  The adjuncti-
ve use of both the agents along with scaling and root 
planing resulted in a significant improvement in all the 
clinical parameters. Although tetracycline fibers resulted 
in better improvement in probing pocket depth reduction 
and relative attachment level gain than chlorhexidine 
gel, more studies with a large sample size are required to 
further assess the comparative clinical efficacy of both 
the local drug delivery agents.
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